首页> 美国卫生研究院文献>Nature Communications >Multifunctional cationic nanosystems for nucleic acid therapy of thoracic aortic dissection
【2h】

Multifunctional cationic nanosystems for nucleic acid therapy of thoracic aortic dissection

机译:用于胸主动脉夹层核酸治疗的多功能阳离子纳米系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thoracic aortic dissection (TAD) is an aggressive vascular disease that requires early diagnosis and effective treatment. However, due to the particular vascular structure and narrowness of lesion location, there are no effective drug delivery systems for the therapy of TAD. Here, we report a multifunctional delivery nanosystem (TP-Gd/miRNA-ColIV) composed of gadolinium-chelated tannic acid (TA), low-toxic cationic PGEA (ethanolamine-aminated poly(glycidyl methacrylate)) and type IV collagen targeted peptide (ColIV) for targeted nucleic acid therapy, early diagnosis and noninvasive monitoring of TAD. Such targeted therapy with miR-145 exhibits impressive performances in stabilizing the vascular structures and preventing the deterioration of TAD. After the treatment with TP-Gd/miR-145-ColIV, nearly no dissection occurs in the thoracic aortic arches of the mice with TAD model. Moreover, TP-Gd/miRNA-ColIV also demonstrates good magnetic resonance imaging (MRI) ability and can be used to noninvasively monitor the development conditions of TAD.
机译:胸主动脉夹层(TAD)是一种侵袭性血管疾病,需要早期诊断和有效治疗。但是,由于特定的血管结构和病变部位狭窄,因此没有有效的药物递送系统可用于TAD的治疗。在这里,我们报告了一种多功能递送纳米系统(TP-Gd / miRNA-ColIV),该系统由g螯合的鞣酸(TA),低毒阳离子PGEA(乙醇胺胺化的聚甲基丙烯酸缩水甘油酯)和IV型胶原蛋白靶向肽( ColIV)用于靶向核酸治疗,TAD的早期诊断和无创监测。用miR-145进行的这种靶向治疗在稳定血管结构和防止TAD恶化方面表现出令人印象深刻的性能。用TP-Gd / miR-145-ColIV处理后,TAD模型小鼠的胸主动脉弓几乎没有解剖。此外,TP-Gd / miRNA-ColIV还表现出良好的磁共振成像(MRI)能力,可用于无创监测TAD的发展状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号